Subpathway-GM: Identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways

Nucleic Acids Research

Volumn 41, Issue 9, 2013, Pages

  Li, Chunquan ^a   Han, Junwei ^a   Yao, Qianlan ^a   Zou, Chendan ^a   Xu, Yanjun ^a   Zhang, Chunlong ^a   Shang, Desi ^a   Zhou, Lingyun ^a   Zou, Chaoxia ^a   Sun, Zeguo ^a   Li, Jing ^a   Zhang, Yunpeng ^a   Yang, Haixiu ^a   Gao, Xu ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; GENE; METABOLIC SUBPATHWAY; METABOLISM; METABOLITE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; SUBPATHWAY GM;

COLORECTAL NEOPLASMS; HISTAMINE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TRANSCRIPTOME;

EID: 84877251556     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt161     Document Type: Article

References (61)

1. Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K.F., Itoh, M., Kawashima, S., Katayama, T., Araki, M. and Hirakawa, M. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 34, D354-D357.
2. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
3. Fang, Z., Tian, W. and Ji, H. (2011) A network-based gene-weighting approach for pathway analysis. Cell Res., 22, 565-580.
4. Pham, L., Christadore, L., Schaus, S. and Kolaczyk, E.D. (2011) Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proc. Natl Acad. Sci. USA, 108, 13347-13352.
5. Chagoyen, M. and Pazos, F. (2011) MBRole: enrichment analysis of metabolomic data. Bioinformatics, 27, 730-731.
6. Xia, J. and Wishart, D.S. (2010) MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics, 26, 2342-2344.
7. Xia, J. and Wishart, D.S. (2010) MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res., 38, W71-W77.
8. Wang, J., Zhou, X., Zhu, J., Gu, Y., Zhao, W., Zou, J. and Guo, Z. (2012) GO-function: deriving biologically relevant functions from statistically significant functions. Brief. Bioinform., 13, 216-227.
9. Li, C., Shang, D., Wang, Y., Li, J., Han, J., Wang, S., Yao, Q., Wang, Y., Zhang, Y., Zhang, C. et al. (2012) Characterizing the network of drugs and their affected metabolic subpathways. PLoS One, 7, e47326.
10. Kamburov, A., Cavill, R., Ebbels, T.M., Herwig, R. and Keun, H.C. (2011) Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics, 27, 2917-2918.
11. Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M. et al. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature, 478, 197-203.
12. Sreekumar, A., Poisson, L.M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R.J., Li, Y. et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457, 910-914.
13. Li, C., Li, X., Miao, Y., Wang, Q., Jiang, W., Xu, C., Li, J., Han, J., Zhang, F., Gong, B. et al. (2009) SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res., 37, e131.
14. Li, X., Li, C., Shang, D., Li, J., Han, J., Miao, Y., Wang, Y., Wang, Q., Li, W., Wu, C. et al. (2011) The implications of relationships between human diseases and metabolic subpathways. PLoS One, 6, e21131.
15. Sabates-Bellver, J., Van der Flier, L.G., de Palo, M., Cattaneo, E., Maake, C., Rehrauer, H., Laczko, E., Kurowski, M.A., Bujnicki, J.M., Menigatti, M. et al. (2007) Transcriptome profile of human colorectal adenomas. Mol. Cancer Res., 5, 1263-1275.
16. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
17. Chan, E.C., Koh, P.K., Mal, M., Cheah, P.Y., Eu, K.W., Backshall, A., Cavill, R., Nicholson, J.K. and Keun, H.C. (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res., 8, 352-361.
18. Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L.X., Cai, S. et al. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res., 8, 4844-4850.
19. Qiu, Y., Cai, G., Su, M., Chen, T., Liu, Y., Xu, Y., Ni, Y., Zhao, A., Cai, S., Xu, L.X. et al. (2010) Urinary metabonomic study on colorectal cancer. J. Proteome Res., 9, 1627-1634.
20. Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M. et al. (2008) Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol. Cancer, 7, 72.
21. Hong, Y., Downey, T., Eu, K.W., Koh, P.K. and Cheah, P.Y. (2010) A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin. Exp. Metastasis, 27, 83-90.
22. Varambally, S., Yu, J., Laxman, B., Rhodes, D.R., Mehra, R., Tomlins, S.A., Shah, R.B., Chandran, U., Monzon, F.A., Becich, M.J. et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell, 8, 393-406.
23. Wishart, D.S., Knox, C., Guo, A.C., Eisner, R., Young, N., Gautam, B., Hau, D.D., Psychogios, N., Dong, E., Bouatra, S. et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res., 37, D603-D610.
24. Becker, K.G., Barnes, K.C., Bright, T.J. and Wang, S.A. (2004) The genetic association database. Nat. Genet., 36, 431-432.
25. Ogata, H., Fujibuchi, W., Goto, S. and Kanehisa, M. (2000) A heuristic graph comparison algorithm and its application to detect functionally related enzyme clusters. Nucleic Acids Res., 28, 4021-4028.
26. Guo, X., Liu, R., Shriver, C.D., Hu, H. and Liebman, M.N. (2006) Assessing semantic similarity measures for the characterization of human regulatory pathways. Bioinformatics, 22, 967-973.
27. Barabasi, A.L., Gulbahce, N. and Loscalzo, J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet., 12, 56-68.
28. Siddiqui, E.J., Thompson, C.S., Mikhailidis, D.P. and Mumtaz, F.H. (2005) The role of serotonin in tumour growth (review). Oncol. Rep., 14, 1593-1597.
29. Liu, X., Newton, R.C., Friedman, S.M. and Scherle, P.A. (2009) Indoleamine 2, 3-dioxygenase, an emerging target for anti-cancer therapy. Curr. Cancer Drug Targets, 9, 938-952.
30. Dizeyi, N., Hedlund, P., Bjartell, A., Tinzl, M., Austild-Tasken, K. and Abrahamsson, P.A. (2009) Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Urol. Oncol., 29, 436-445.
31. Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N. and Abrahamsson, P.A. (2004) Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate, 59, 328-336.
32. Griffin, J.L. and Shockcor, J.P. (2004) Metabolic profiles of cancer cells. Nat. Rev. Cancer, 4, 551-561.
33. Cairns, R.A., Harris, I.S. and Mak, T.W. (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer, 11, 85-95.
34. Jelski, W., Mroczko, B. and Szmitkowski, M. (2010) The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of colorectal cancer patients. Dig. Dis. Sci., 55, 2953-2957.
35. Bunney, T.D. and Katan, M. (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat. Rev. Cancer, 10, 342-352.
36. Sauer, K. and Cooke, M.P. (2010) Regulation of immune cell development through soluble inositol-1, 3, 4, 5-tetrakisphosphate. Nat. Rev. Immunol., 10, 257-271.
37. Vucenik, I. and Shamsuddin, A.M. (2003) Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J. Nutr., 133, 3778S-3784S.
38. Cianchi, F., Vinci, M.C. and Masini, E. (2008) Histamine in cancer: the dual faces of the coin. Cancer Biol. Ther., 7, 36-37.
39. Cianchi, F., Cortesini, C., Schiavone, N., Perna, F., Magnelli, L., Fanti, E., Bani, D., Messerini, L., Fabbroni, V., Perigli, G. et al. (2005) The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin. Cancer Res., 11, 6807-6815.
40. Jones, R., Adel-Alvarez, L.A., Alvarez, O.R., Broaddus, R. and Das, S. (2003) Arachidonic acid and colorectal carcinogenesis. Mol. Cell Biochem., 253, 141-149.
41. Hyde, C.A. and Missailidis, S. (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int. Immunopharmacol., 9, 701-715.
42. Avis, I., Hong, S.H., Martinez, A., Moody, T., Choi, Y.H., Trepel, J., Das, R., Jett, M. and Mulshine, J.L. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J., 15, 2007-2009.
43. Stabler, S., Koyama, T., Zhao, Z., Martinez-Ferrer, M., Allen, R.H., Luka, Z., Loukachevitch, L.V., Clark, P.E., Wagner, C. and Bhowmick, N.A. (2011) Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS One, 6, e22486.
44. Lambert, J.D., Sang, S., Hong, J. and Yang, C.S. (2010) Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate. J. Agric. Food Chem., 58, 10016-10019.
45. Nie, D., Che, M., Grignon, D., Tang, K. and Honn, K.V. (2001) Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev., 20, 195-206.
46. Dinu, I., Potter, J.D., Mueller, T., Liu, Q., Adewale, A.J., Jhangri, G.S., Einecke, G., Famulski, K.S., Halloran, P. and Yasui, Y. (2009) Gene-set analysis and reduction. Brief. Bioinform., 10, 24-34.
47. Moon, M.S., Cho, E.W., Byun, H.S., Jung, I.L. and Kim, I.G. (2004) GAD 67KD antisense in colon cancer cells inhibits cell growth and sensitizes to butyrate and pH reduction and H2O2 and gamma-radiation. Arch. Biochem. Biophys., 430, 229-236.
48. Matuszek, M., Jesipowicz, M. and Kleinrok, Z. (2001) GABA content and GAD activity in gastric cancer. Med. Sci. Monit., 7, 377-381.
49. Itoh, Y.F.A.K. (2010) A plasma metabolomic investigation of colorectal cancer patients by liquid chromatography-mass spectrometry. The Open Analytical Chemistry Journal, 4, 1-9.
50. Wang, H., Tso, V.K., Slupsky, C.M. and Fedorak, R.N. (2010) Metabolomics and detection of colorectal cancer in humans: a systematic review. Future Oncol., 6, 1395-1406.
51. Thangaraju, M., Carswell, K.N., Prasad, P.D. and Ganapathy, V. (2009) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem. J., 417, 379-389.
52. Yeh, C.L., Pai, M.H., Li, C.C., Tsai, Y.L. and Yeh, S.L. (2010) Effect of arginine on angiogenesis induced by human colon cancer: in vitro and in vivo studies. J. Nutr. Biochem., 21, 538-543.
53. Eisenhofer, G., Kopin, I.J. and Goldstein, D.S. (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol. Rev., 56, 331-349.
54. Sertel, S., Eichhorn, T., Simon, C.H., Plinkert, P.K., Johnson, S.W. and Efferth, T. (2010) Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines. Molecules, 15, 2886-2910.
55. Horst, D., Budczies, J., Brabletz, T., Kirchner, T. and Hlubek, F. (2009) Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer. Cancer, 115, 4946-4958.
56. Zhang, X., Bi, C., Fan, Y., Cui, Q., Chen, D., Xiao, Y. and Dou, Q.P. (2008) Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity. Int. J. Mol. Med., 22, 677-682.
57. Ebert, B., Kisiela, M., Wsol, V. and Maser, E. (2011) Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem. Biol. Interact., 191, 239-249.
58. Sakurai, K., Enomoto, K., Matsuo, S., Amano, S. and Shiono, M. (2011) CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer. Surg. Today, 41, 674-679.
59. Afzal, S., Gusella, M., Vainer, B., Vogel, U.B., Andersen, J.T., Broedbaek, K., Petersen, M., Jimenez-Solem, E., Bertolaso, L., Barile, C. et al. (2011) Combinations of polymorphisms in genes involved in the 5-fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients. Clin. Cancer Res., 17, 3822-3829.
60. Avis, I., Hong, S.H., Martinez, A., Moody, T., Choi, Y.H., Trepel, J., Das, R., Jett, M. and Mulshine, J.L. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J., 15, 2007-2009.
61. Lambert, J.D., Sang, S., Hong, J. and Yang, C.S. (2010) Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate. J. Agric. Food Chem., 58, 10016-10019.